Todd A. Brugel

692 total citations
20 papers, 415 citations indexed

About

Todd A. Brugel is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Todd A. Brugel has authored 20 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Todd A. Brugel's work include Synthesis and biological activity (10 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Quinazolinone synthesis and applications (4 papers). Todd A. Brugel is often cited by papers focused on Synthesis and biological activity (10 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Quinazolinone synthesis and applications (4 papers). Todd A. Brugel collaborates with scholars based in United States, Germany and Singapore. Todd A. Brugel's co-authors include David R. Williams, M. Sabat, Biswanath De, Adam Gołȩbiowski, Matthew J. Laufersweiler, John C. VanRens, Lily C. Hsieh, Michael J. Janusz, Richard L. Walter and Marlene Mekel and has published in prestigious journals such as The Journal of Organic Chemistry, Organic Letters and European Journal of Pharmacology.

In The Last Decade

Todd A. Brugel

20 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd A. Brugel United States	13	279	134	64	53	36	20	415
Michael R. Palovich United States	14	268 1.0×	131 1.0×	78 1.2×	22 0.4×	47 1.3×	22	515
Dramane I. Lainé United States	14	238 0.9×	193 1.4×	35 0.5×	26 0.5×	50 1.4×	29	528
Rabindranath Tripathy United States	14	425 1.5×	212 1.6×	60 0.9×	32 0.6×	16 0.4×	18	610
David J. Madar United States	13	427 1.5×	255 1.9×	77 1.2×	33 0.6×	26 0.7×	20	639
Bernard Portevin France	11	270 1.0×	198 1.5×	102 1.6×	87 1.6×	34 0.9×	16	483
Terrence L. Smalley United States	12	263 0.9×	224 1.7×	79 1.2×	28 0.5×	32 0.9×	20	551
Ana Carolina Barrios Sosa United States	14	291 1.0×	170 1.3×	48 0.8×	15 0.3×	31 0.9×	24	458
Peter Wipf United States	16	381 1.4×	227 1.7×	27 0.4×	30 0.6×	17 0.5×	30	618
Daniele M. Leonard United States	12	178 0.6×	323 2.4×	107 1.7×	35 0.7×	31 0.9×	17	481
J.K.Y. Wong United States	11	238 0.9×	272 2.0×	61 1.0×	15 0.3×	44 1.2×	28	498

Countries citing papers authored by Todd A. Brugel

Since Specialization

Citations

This map shows the geographic impact of Todd A. Brugel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd A. Brugel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd A. Brugel more than expected).

Fields of papers citing papers by Todd A. Brugel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd A. Brugel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd A. Brugel. The network helps show where Todd A. Brugel may publish in the future.

Co-authorship network of co-authors of Todd A. Brugel

This figure shows the co-authorship network connecting the top 25 collaborators of Todd A. Brugel. A scholar is included among the top collaborators of Todd A. Brugel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd A. Brugel. Todd A. Brugel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peters, Matthew F., Anna Zacco, John Gordon, et al.. (2011). Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity. European Journal of Pharmacology. 661(1-3). 27–34. 44 indexed citations

Brugel, Todd A., Christopher Becker, Gerard M. Koether, et al.. (2010). SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2. Bioorganic & Medicinal Chemistry Letters. 20(18). 5405–5410. 16 indexed citations

Varnes, Jeffrey, Christopher R. Holmquist, Deidre Wilkins, et al.. (2010). Identification of N-(2-(azepan-1-yl)-2-phenylethyl)-benzenesulfonamides as novel inhibitors of GlyT1. Bioorganic & Medicinal Chemistry Letters. 20(16). 4878–4881. 3 indexed citations

Sabat, M., John C. VanRens, Michael P. Clark, et al.. (2006). The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production. Bioorganic & Medicinal Chemistry Letters. 16(16). 4360–4365. 11 indexed citations

Williams, David R., David C. Ihle, Todd A. Brugel, & Samarjit Patnaik. (2006). Investigations of Pd-Catalyzed Aryl Substitution Reactions. A Case Study towards Zoanthenol. Heterocycles. 70(1). 77–77. 11 indexed citations

Sabat, M., John C. VanRens, Matthew J. Laufersweiler, et al.. (2006). The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck). Bioorganic & Medicinal Chemistry Letters. 16(23). 5973–5977. 57 indexed citations

Maier, Jennifer A., Todd A. Brugel, M. Sabat, et al.. (2006). Development of N-4,6-pyrimidine-N-alkyl-N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 16(14). 3646–3650. 12 indexed citations

Clark, Michael P., Kelly M. George, Roger G. Bookland, et al.. (2006). Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3). Bioorganic & Medicinal Chemistry Letters. 17(5). 1250–1253. 50 indexed citations

Brugel, Todd A., Jennifer A. Maier, Michael P. Clark, et al.. (2006). Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1. Bioorganic & Medicinal Chemistry Letters. 16(13). 3510–3513. 15 indexed citations

10.

Sabat, M., John C. VanRens, Todd A. Brugel, et al.. (2006). The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). Bioorganic & Medicinal Chemistry Letters. 16(16). 4257–4261. 18 indexed citations

11.

Maier, Jennifer A., Todd A. Brugel, Michael P. Clark, et al.. (2006). Development of N-2,4-pyrimidine-N-phenyl-N′-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2. Bioorganic & Medicinal Chemistry Letters. 16(13). 3514–3518. 7 indexed citations

12.

Brugel, Todd A., Tomáš Hudlický, Michael P. Clark, et al.. (2006). Convergent synthesis of 2,3-bisarylpyrazolones through cyclization of bisacylated pyrazolidines and hydrazines. Tetrahedron Letters. 47(19). 3195–3198. 6 indexed citations

13.

Sabat, M., John C. VanRens, Todd A. Brugel, et al.. (2006). Synthesis of Novel Pyrimido[4,5-c]pyridazines and 1,2-Dihydro-3a,7,9,9b-Tetraaza-cyclopenta[a]naphthalen-3-ones as Potent Inhibitors of Lymphocyte Specific Kinase (LCK). Heterocycles. 68(10). 2037–2037. 1 indexed citations

14.

Clark, Michael P., Adam Gołȩbiowski, Todd A. Brugel, et al.. (2005). The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production. Bioorganic & Medicinal Chemistry Letters. 15(9). 2399–2403. 49 indexed citations

15.

Gołȩbiowski, Adam, Matthew J. Laufersweiler, Todd A. Brugel, et al.. (2005). The development of monocyclic pyrazolone based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(9). 2285–2289. 20 indexed citations

16.

Laufersweiler, Matthew J., Todd A. Brugel, Michael P. Clark, et al.. (2004). The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones. Bioorganic & Medicinal Chemistry Letters. 14(16). 4267–4272. 17 indexed citations

17.

Gołȩbiowski, Adam, Michael P. Clark, Matthew J. Laufersweiler, et al.. (2004). The development of new bicyclic pyrazole-based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4945–4948. 17 indexed citations

18.

Brugel, Todd A. & Louis S. Hegedus. (2003). N-Functionalization of Poly(ethylene glycol)-Linked Mono- and Bis-dioxocyclams as Potential Ligands for Gd³⁺. The Journal of Organic Chemistry. 68(22). 8409–8415. 13 indexed citations

19.

Williams, David R. & Todd A. Brugel. (2000). Intramolecular Diels−Alder Cyclizations of (E)-1-Nitro-1,7,9-decatrienes: Synthesis of the AB Ring System of Norzoanthamine. Organic Letters. 2(8). 1023–1026. 42 indexed citations

20.

Brugel, Todd A. & Brian Wesley Williams. (1993). Synthesis and characterization of a solvatochromic, lipophilic fluorescent oxazone: 1-Pentyl-7-dimethylamino-3H-phenoxazine-3-one. Journal of Fluorescence. 3(2). 69–76. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact